Oxford Biomedica
World Rank (Jan-05-2024)
16,733
Market Cap (Jan-05-2024)
0.250 Billion USD
World Rank (Jul-30-2023)
12,183
Market Cap (Jul-30-2023)
0.545 Billion USD
World Rank (Dec-25-2022)
12,381
Market Cap (Dec-25-2022)
0.502 Billion USD
World Rank (Jan-07-2022)
8,157
Market Cap (Jan-07-2022)
1.28 Billion USD
Annual Revenue in USD
179 Million USD
Annual Net Income in USD
-50 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Company Profile
Oxford Biomedica is a Pioneer of gene and cell therapy with a position in Lentiviral Vector Research, Development and Bioprocessing company. It have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders and provide with multiple income streams, consisting of upfront milestone payments, development and production fees and potential royalties on future product sales. The headquarters is in UK.
Company Website
Wikipedia